TRVI vs. GDXJ
TRVI (Trevi Therapeutics, Inc.) is a stock, while GDXJ (VanEck Junior Gold Miners ETF) is Gold fund tracking the MVIS Global Junior Gold Miners Index. Over the past 5 years, TRVI returned 44.83%/yr vs 16.23%/yr for GDXJ. At a 0.08 correlation, their price movements are largely independent.
Performance
TRVI vs. GDXJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRVI achieves a 13.50% return, which is significantly higher than GDXJ's -8.37% return.
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
GDXJ
- 1D
- 3.15%
- 1M
- -19.14%
- YTD
- -8.37%
- 6M
- -6.68%
- 1Y
- 51.06%
- 3Y*
- 44.17%
- 5Y*
- 16.23%
- 10Y*
- 12.00%
TRVI vs. GDXJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
GDXJ VanEck Junior Gold Miners ETF | -8.37% | 172.28% | 15.67% | 7.12% | -14.53% | -21.25% | 30.40% | 48.97% |
Correlation
The correlation between TRVI and GDXJ is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.08 |
The correlation between TRVI and GDXJ shifts across timeframes, from 0.08 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRVI vs. GDXJ — Risk / Return Rank
TRVI
GDXJ
TRVI vs. GDXJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and VanEck Junior Gold Miners ETF (GDXJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRVI | GDXJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.18 | ||
| Sortino ratioReturn per unit of downside risk | +1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.20 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 4.44 | 1.30 | +3.14 |
| Martin ratioReturn relative to average drawdown | 10.40 | 3.55 | +6.84 |
Loading charts...
Drawdowns
TRVI vs. GDXJ - Drawdown Comparison
The maximum TRVI drawdown since its inception was -95.45%, which is greater than GDXJ's maximum drawdown of -88.66%. Use the drawdown chart below to compare losses from any high point for TRVI and GDXJ.
Loading charts...
Drawdown Indicators
| TRVI | GDXJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.45% | -88.66% | -6.79% |
Max Drawdown (1Y)Largest decline over 1 year | -29.50% | -39.47% | +9.97% |
Max Drawdown (3Y)Largest decline over 3 years | -61.96% | -39.47% | -22.49% |
Max Drawdown (5Y)Largest decline over 5 years | -80.26% | -49.76% | -30.50% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.77% | — |
Current DrawdownCurrent decline from peak | -7.73% | -33.25% | +25.52% |
Average DrawdownAverage peak-to-trough decline | -61.49% | -60.45% | -1.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.58% | 14.41% | -1.83% |
Volatility
TRVI vs. GDXJ - Volatility Comparison
The current volatility for Trevi Therapeutics, Inc. (TRVI) is 13.78%, while VanEck Junior Gold Miners ETF (GDXJ) has a volatility of 19.46%. This indicates that TRVI experiences smaller price fluctuations and is considered to be less risky than GDXJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRVI | GDXJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.78% | 19.46% | -5.68% |
Volatility (6M)Calculated over the trailing 6-month period | 39.38% | 43.41% | -4.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.39% | 51.54% | +8.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.26% | 41.50% | +46.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.35% | 44.23% | +55.12% |
Dividends
TRVI vs. GDXJ - Dividend Comparison
TRVI has not paid dividends to shareholders, while GDXJ's dividend yield for the trailing twelve months is around 2.54%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GDXJ VanEck Junior Gold Miners ETF | 2.54% | 2.33% | 2.61% | 0.72% | 0.51% | 1.78% | 1.58% | 0.39% | 0.45% | 0.03% | 4.78% | 0.72% |
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TRVI and GDXJ have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GDXJ has higher volatility (19.46%) compared to TRVI (13.78%). In terms of maximum drawdown, TRVI dropped -95.45% vs GDXJ's -88.66%.
TRVI currently has the higher Sharpe Ratio (2.17 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRVI and GDXJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer